Entellus Medical to Present at William Blair 35th Annual Growth Stock Conference
May 26 2015 - 4:02PM
Entellus Medical, Inc. (Nasdaq:ENTL), a medical technology company
focused on products for the minimally invasive treatment of chronic
and recurrent sinusitis patients in the physician office setting or
operating room, today announced the company plans to participate in
the William Blair 35th Annual Growth Stock Conference in Chicago,
IL.
Entellus Medical's management is scheduled to present on
Wednesday, June 10, 2015 at 4:40pm CT. Interested parties can
access the live audio webcast at http://www.entellusmedical.com. An
archived presentation will be available on the website for 30
days.
About Entellus Medical, Inc.
Entellus Medical is a medical technology company focused on the
design, development and commercialization of products for the
minimally invasive treatment of chronic and recurrent sinusitis
patients in the physician office setting or operating room. Its
XprESS family of products is used by ENT physicians to open
narrowed or obstructed sinus drainage pathways using balloon sinus
dilation. When used as a stand-alone therapy, Entellus Medical's
balloon sinus dilation products are the only devices proven in a
sufficiently powered prospective, multicenter, randomized,
controlled trial to be as effective as functional endoscopic sinus
surgery, or FESS. Patients treated with Entellus Medical's products
in this trial in the ENT physician office also experienced faster
recovery, less bleeding at discharge, less use of prescription pain
medication and fewer post-procedure debridements than patients
receiving FESS. Entellus Medical currently markets its products in
the United States and Canada and sells its products through a
direct sales force in the United States.
CONTACT: Leigh Salvo
415-513-1281
ir@entellusmedical.com
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENTELLUS MEDICAL INC (NASDAQ:ENTL)
Historical Stock Chart
From Jul 2023 to Jul 2024